Gilles Besin

Gilles Besin

Company: Orbital Therapeutics

Job title: Chief Scientific Officer

Seminars:

Chair’s Opening Remarks 8:50 am

Read more

day: Conference Day One

Chairs Closing Remarks & End of Conference Day One 5:15 pm

Read more

day: Conference Day One

Fireside Chat: Unlocking Priorities for the Next Generation RNA Community to Increase Investment for Driving More Therapeutics to the Patients in Need 9:30 am

• What innovations need to come through to unleash the next frontiers in next generation RNA therapeutic development? • Identifying future trends and opportunities within investment for circular and self-amplifying RNA therapeutics • Highlighting priority actions for the circular and self-amplifying RNA community to drive success in 2025Read more

day: Conference Day Two

Deep-Dive Workshop: Understanding Circular & Self-Amplifying RNAs Unique Potential as More Durable & Stable Therapeutics for Treating Patients in Need 11:15 am

• Circular RNA and self-amplifying RNA have many differences to linear mRNA, they have greater stability and durability, however, it’s vital to understand how these properties can be taken advantage of for developing efficacious and safe therapeutics to treat a wide array of diseases which are currently undruggable. This session will deep dive into: •…Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.